Proposal Brief
Icon

Industry

Pharmaceuticals

Icon

Sub Industry

Generic Pharmaceuticals

Icon

Deal Size

INR 100 - 500 Cr

Icon

Preferred Location

India

Icon

Region

Across India

Icon

Looking to acquire

B2B, B2C Manufacturing businesses (Own Brand & Contract Manufacturing)

Icon

Open for Distressed Assets

No

Icon

Minimum Revenue

INR 50 Cr

Target Requirement

Description of buyer :  leading India-based pharmaceutical company which offers a portfolio of products and services, including APIs, CPS, generics, biosimilars and
differentiated formulations. 

Target areas of acquisition : Active Pharmaceutical Ingredients (APIs), Over-the-counter drugs (OTC), generics, biosimilars, and differentiated formulations. Entry level acquisition in OTC Products, branded generics in key therapeutic areas

Focus areas : Oncology, Gastroenterology, Antidiabetic, Antibiotics, Cardiovascular, Pain Management, Gynecology

Reason for acquisition : India is a global leader in the production of generic drugs. With many patents of branded drugs expiring, Indian pharmaceutical companies have the
opportunity to capture a larger market share by offering affordable generic alternatives, both domestically and internationally

 

Business Operation Information
Business Documents